Neumitra Files IPO Prospectus: Wearable Tech for Real-Time Stress Detection and Management

In modern society, the fast pace of life and high work pressure mean that everyone has likely experienced, to varying degrees, mental health challenges. If you have ever inexplicably felt shortness of breath or a rapid heartbeat, if these reactions have affected your work or study efficiency, and if you wish to identify the triggers behind such physiological responses to improve your quality of life and alleviate stress, then Neumitra may be exactly what you need. It detects increases in sweat volume and body temperature caused by stress or excitement, and relays this information to the wearer.

Figure: Neumitra's wrist-worn sensor

As a young technology company founded in 2010, Neumitra is dedicated to helping people measure and manage the impact of daily activities on brain health and executive function. Its design philosophy is straightforward: since stress can trigger a series of physiological responses, such as sweating, accelerated breathing, and increased heart rate, continuous and accurate monitoring of these vital signs enables us to predict the onset of stress.

Product Introduction
So, what is the biological rationale behind this design?
We all know that sweat glands and the stress response are controlled by the same region of the nervous system. This means that by measuring the electrical conductivity of the skin on the fingers, palms, and soles of the feet, we can partially assess the body’s current stress levels. Generally speaking, the more one sweats, the higher the skin conductivity, which correspondingly indicates a higher level of cerebral stress. Therefore, skin conductivity can serve as an indicator for measuring brain stress.
Using Neumitra is simple: users wear the wrist-worn sensor, Neuma, which accurately and continuously measures autonomic nervous system data across various daily life scenarios. The longitudinal data collected by Neuma—such as events, locations, and activities—is then analyzed by the companion mobile app to identify spontaneously occurring symptoms and determine their underlying causes. When the sensor detects signs of impending stress, it alerts the wearer through vibration, enabling them to prepare in advance and avoid situations that may trigger anxiety.

Figure: Screenshot of the Neumitra APP. The colored blocks represent the stress levels perceived by the user during each activity. In the orange sections, a deeper color indicates higher stress; in the blue sections, a deeper color indicates lower stress.

Figure: Screenshot of the Neumitra APP. The locations shown indicate where the user experienced stress. Red areas represent higher stress levels, while blue areas represent lower stress levels.

Currently, Neumitra offers three products: wearable devices, a desktop computing system, and a mobile app. These work together to integrate data for managing brain health and assessing its impact on daily life. At present, the only device available for purchase is Neuma, a wrist-worn sensor priced at $1,500, which remains a significant expense for most people.

Application Scenarios
Imagine wearing Neuma while driving. As you pass through a certain section of road or location, the device suddenly vibrates, alerting you to the onset of a stress response in your body. The next time, you can avoid that route, thereby reducing the likelihood of experiencing stress. Alternatively, suppose you are intensely preparing for an upcoming exam, and Neuma begins to vibrate. This signals that your brain is already registering stress. By taking a deep breath, listening to soothing music, or having a conversation with someone, you may successfully ward off an episode of stress.

Typically, we only realize that we have entered a high-stress situation after stress levels have accumulated to a certain point, leaving us physically and mentally overwhelmed with pronounced anxiety. Prolonged exposure to such states can lead to adverse effects, including memory decline, emotional instability, difficulty concentrating, and even weakened immunity. The emergence of Neumitra offers hope for neutralizing stress before it takes hold.

In addition to helping individuals manage and control stress, Neumitra also offers the following services:
For research institutions and clinicians, Neuma can measure the sympathetic nervous system with accuracy comparable to that of clinical studies. Study participants can obtain continuous sympathetic nerve data via Neuma, while a mobile app facilitates the collection of additional physical data, such as location, events, and activities.
For corporate groups, Neuma enables real-time monitoring of employee stress levels and analysis of overall emotional states, with a particular focus on emotional data during deadlines and meetings. This allows companies to assess the impact of emotional well-being on employee productivity and organizational operations.

Bottlenecks, Current Status, and Future
Dr. Robert Goldberg, a neuroscience researcher and one of the three founders of Neumitra, graduated from the Massachusetts Institute of Technology (MIT) in the United States. The other two co-founders are Safiyy Momen, a computer algorithm engineer, and Anand Yadav, a biotechnologist. The trio met in 2009 at MIT’s Neurotechnology Ventures class. Regarding the inspiration for founding the company, Dr. Goldberg stated that it stemmed from a real-life case involving a veteran suffering from anxiety disorder. After three years of treatment, the veteran finally realized that his anxiety was triggered by supermarkets filled with food products. The sudden appearance of strangers holding items between aisles made him feel threatened. “For him, the sight of shelves stocked with food was a trigger. With Neumitra, we were able to identify this within just one week,” said Dr. Goldberg.

Figure: Neumitra founders. From left to right: Safiyy Momen, Anand Yadav, Robert Goldberg

In addition to its high price, Neumitra faces two other challenges if it aims to achieve broader adoption. First, scientific research has not yet been able to distinguish symptoms caused by psychological stress from physiological characteristics generated by physical exercise. Second, the accuracy of the device’s measurements needs improvement. In 2012, a study was conducted on a type of pressure sensor based on skin-contact principles. The results showed that the physiological feedback provided by the sensor when the wearer was laughing or engaging in physical exercise was identical to the feedback recorded under stress conditions. Neumitra users may encounter similar issues.

To address these drawbacks, Goldberg is also exploring ways to improve device accuracy, such as embedding additional sensors into wrist-worn devices. However, to obtain comprehensive and precise information, he still recommends that users input relevant medical data from other sources into the software. Of course, the best approach may be to maintain close communication with one’s physician.

Nevertheless, despite certain drawbacks, Neumitra remains one of the first vendors to launch devices designed to capture complex and critical implicit information. By measuring the specific effects of daily stressors on the autonomic nervous system and acquiring extensive physiological data, Neumitra is dedicated to elucidating, through rigorous analysis of such data, the mechanisms by which daily lifestyle behaviors impact brain health and performance.
Currently, over 40 million Americans suffer from clinical anxiety disorders, and physicians prescribe more than 200 million doses of tranquilizers annually. Meanwhile, as Goldberg notes, approximately 30% of military personnel who have served in overseas conflicts are diagnosed with post-traumatic stress disorder (PTSD) upon discharge. Excessive work and life stress have triggered a cascade of adverse outcomes, including sleep deprivation, poor nutrition, and physical inactivity. Moreover, modern individuals are paying increasing attention to their physical health, extending even to detailed monitoring of dietary intake; stress, as an emerging “health killer,” is no exception. In this context, Neumitra’s market prospects appear highly promising if it can successfully address the aforementioned challenges. Perhaps in the near future, stress levels will become a routine health metric, alongside blood pressure, heart rate, and other standard physiological indicators.

Financing Status
Neumitra was founded in 2010, with its headquarters located in Boston, USA. In October 2010, the company secured a seed funding round with an undisclosed amount. In June 2012, Rock Health made a seed investment in Neumitra, with the amount not disclosed; later that same month, Rock Health provided additional seed funding of $20,000.

(Compiled by: Lv Xiaoyi; Edited by: Zhang Nan)

Part 4 of the Series: The 30 Most Noteworthy Healthcare Startups to Watch in 2015Recombine: Genetic Analysis Enables Personalized Eugenics and Optimal Childbearing

The 30 Most Notable Healthcare Startups to Watch in 2015, Part 5:Transcriptic: Solving the Most Painful Problems for Lab Technicians

Part 6 of the Series: The 30 Most Notable Healthcare Startups to Watch in 2015Zipnosis: Asynchronous Telemedicine Enables Patients to Receive Care for Common Conditions at Home

Part 7 of the Series: 30 Most Noteworthy Healthcare Startups to Watch in 2015:Sherpaa: The Online Consultation Company That Retains Every Customer

Part 8 of the Series: 30 Most Noteworthy Healthcare Startups to Watch in 2015Abiogenix: Developing the uBox Smart Box to Remind Patients to Take Medication on Time

Part 9 of the Series: 30 Most Noteworthy Healthcare Startups to Watch in 2015Omada Health: Digital Behavioral Therapy for Chronic Disease Management

Part 10 of the Series: 30 Most Notable Healthcare Startups to Watch in 2015:BetterDoctor: Online Doctor Search—Choose to Book the Best Doctors

Part 11 of the Series: The 30 Most Notable Healthcare Startups to Watch in 2015:goBalto: Accelerating Drug Development onto the Fast Track

Part 12 of the Series: The 30 Most Notable Healthcare Startups to Watch in 2015:NeuroTrack: Predicting Alzheimer’s Disease 3 to 6 Years in Advance

Series on the 30 Most Notable Healthcare Startups of 2015, Part 13:Medicast: Open the mobile app to easily summon a doctor for a house call.

Previously, VCBeat introduced the 30 most undervalued healthcare startups worth watching in 2015 (Click here for details), VCBeat will continue to monitor the developments of these 30 companies and provide our readers with the latest in-depth reports on them.